The Latest in Rheumatology

Internal Medicine News

Dazodalibep may mitigate Sjögren’s syndrome, but more data are needed

June 12, 2023

Rheumatology

Internal Medicine News

Why not both? Dual biologics for treatment-resistant RA and PsA

June 12, 2023

Rheumatology

Internal Medicine News

EULAR PsA recommendations update emphasizes safety, nonmusculoskeletal manifestations

June 9, 2023

Rheumatology

Internal Medicine News

Long COVID risk not higher with rheumatic diseases

June 8, 2023

Internal Medicine News

Studies reveal nuances in efficacy, MACE risk between JAKi and TNFi

June 7, 2023

Rheumatology

Internal Medicine News

Gout linked to smaller brain volume, higher likelihood of neurodegenerative diseases

June 7, 2023

Internal Medicine News

Cell activity in psoriasis may predict disease severity and provide clues to comorbidities

June 7, 2023

Internal Medicine News

Early axial spondyloarthritis diagnosis in referred patients remains stable in most

June 6, 2023

Rheumatology

Internal Medicine News

Investigational uricase-based gout drug meets primary endpoints in phase 3 trials

June 6, 2023

Rheumatology

Internal Medicine News

EULAR systemic sclerosis recommendations now include immunosuppressants

June 5, 2023

Internal Medicine News

URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial

June 5, 2023

Rheumatology

Internal Medicine News

Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’s

June 2, 2023

Rheumatology

Internal Medicine News

Scientists discover variants, therapy for disabling pansclerotic morphea

June 2, 2023

Internal Medicine News

Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis

June 1, 2023

Internal Medicine News

Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 years

June 1, 2023

Rheumatology